Persistent interleukin-1beta signaling causes long term activation of NFkappaB in a promoter-specific manner in human glial cells.
about
HIV-1, methamphetamine and astrocytes at neuroinflammatory CrossroadsBiomechanical signals suppress TAK1 activation to inhibit NF-kappaB transcriptional activation in fibrochondrocytesSignal transduction pathways (MAPKs, NF-κB, and C/EBP) regulating COX-2 expression in nasal fibroblasts from asthma patients with aspirin intolerance.Contribution of Primary Afferent Input to Trigeminal Astroglial Hyperactivity, Cytokine Induction and NMDA Receptor Phosphorylation.Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic miceThe role of tumour necrosis factor-α and tumour necrosis factor receptor signalling in inflammation-associated systemic genotoxicity.Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways.The TGF-beta paradox in human cancer: an update.Interleukins in glioblastoma pathophysiology: implications for therapy.Cytokines: shifting the balance between glioma cells and tumor microenvironment after irradiation.In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activationRas regulates interleukin-1β-induced HIF-1α transcriptional activity in glioblastoma.DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytesSpecific NFkappaB subunit activation and kinetics of cytokine induction in adenoviral keratitis.p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells.RUNX1 Regulates Migration, Invasion, and Angiogenesis via p38 MAPK Pathway in Human Glioblastoma.
P2860
Q28392199-0AE0A123-CB0B-4254-9520-BF2F5849F83CQ28578466-42043D3A-65E3-4E35-98AA-579D56D56084Q30459926-49311103-9314-41F8-9D8F-70010BBF5BE9Q34410441-DFDDA867-5FD9-40CF-BBE2-D2C479D89128Q35559749-09B41D10-CA7F-45F1-BEC3-433981D8E85AQ35621836-4751730C-FC61-49A5-9D43-EB8CE1372774Q35663498-9D0E982E-9CE8-4505-B2E0-2475011DAA0DQ37261631-4B3CE06D-96AA-4D75-B272-88C9AFC1CCECQ38051761-8D226D82-62F3-42E1-AD7B-9C2FD9A2A5C8Q38227496-CEBE3BCC-B28D-45AB-BC35-3C6F3A105DBBQ39086029-2F066704-FCC1-40F5-9CF1-219F2ECFC4CCQ39652050-34878898-21AD-4868-889F-5A7FE647EA26Q42117977-8576E308-0F68-47A9-AC57-DA4AF5CBD3E3Q42948998-3B803B8D-EA87-496F-A600-C0E09A3E5E4DQ48552243-D1BCD7B9-317F-48DF-A270-9F546D5B36BEQ51238685-3FF2D8DB-536C-4141-B910-16B3426D061B
P2860
Persistent interleukin-1beta signaling causes long term activation of NFkappaB in a promoter-specific manner in human glial cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Persistent interleukin-1beta s ...... c manner in human glial cells.
@en
type
label
Persistent interleukin-1beta s ...... c manner in human glial cells.
@en
prefLabel
Persistent interleukin-1beta s ...... c manner in human glial cells.
@en
P2860
P356
P1476
Persistent interleukin-1beta s ...... c manner in human glial cells.
@en
P2093
Bryan D Griffin
P2860
P304
10316-10326
P356
10.1074/JBC.M509973200
P407
P577
2006-02-02T00:00:00Z